ANTIGENBINDENDES PROTEIN GEGEN HER3
European patent · EP3512886 · In force
Register entry
- Publication number
- EP3512886
- Application number
- EP17768777
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 15, 2017
- Published
- Jul 24, 2019
- Granted
- Jun 11, 2025
- Protection ends at the latest
- Sep 14, 2037
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61K 39/00 (2006.01)A61P 35/00 (2006.01)C07K 16/28 (2006.01)C07K 16/30 (2006.01)C07K 16/32 (2006.01)
- Priority
- EP 16188871 15.09.2016
- PCT application
- PCT/EP2017/073328 15.09.2017
- PCT publication
- WO2018/050848 22.03.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Apr 23, 2026
Change
Published in Swissreg on 23.04.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Jul 14, 2025
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 14.07.2025
- Jun 11, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 11.06.2025
Parties
Inventor
72622 Nürtingen, DE
69168 Wiesloch, DE
73614 Schorndorf, DE
70437 Stuttgart, DE
70469 Stuttgart, DE
38118 Braunschweig, DE
38108 Braunschweig, DE
80339 München, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.